PW Medtech Group Limited

HKSE 1358.HK

PW Medtech Group Limited Price to Sales Ratio (P/S) on January 14, 2025: 1.87

PW Medtech Group Limited Price to Sales Ratio (P/S) is 1.87 on January 14, 2025, a 12.24% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • PW Medtech Group Limited 52-week high Price to Sales Ratio (P/S) is 2.43 on July 29, 2024, which is 30.11% above the current Price to Sales Ratio (P/S).
  • PW Medtech Group Limited 52-week low Price to Sales Ratio (P/S) is 1.48 on January 31, 2024, which is -20.50% below the current Price to Sales Ratio (P/S).
  • PW Medtech Group Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 2.02.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
HKSE: 1358.HK

PW Medtech Group Limited

CEO Ms. Yue'e Zhang
IPO Date Nov. 8, 2013
Location China
Headquarters Building 1
Employees 1,302
Sector Health Care
Industries
Medical Instruments Pharmaceuticals Private Equity
Description

PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People's Republic of China. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens. It also provides property management services. The company was formerly known as Pyholding Limited. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Similar companies

1345.HK

China Pioneer Pharma Holdings Limited

USD 0.30

-0.02%

1349.HK

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

USD 0.29

2.68%

StockViz Staff

January 15, 2025

Any question? Send us an email